Fusion rapidly advancing their R&D MAL validation programme with successful SARS-CoV-2 antigens created for commercial use, moving onto the next step, finding a neutralising antibody for the disease. I meant to cover the news from Fusion Antibodies (FAB) last week when it was announced but the news landed whilst I was under the knife havingContinue reading “Are Fusion on a pathway to finding the Holy Grail ?”